Pharmaceuticals, Biotechnology and Life Sciences
-Lexicon to receive an upfront payment of $25 million and the potential for contingent regulatory and commercial milestone paymentsTHE WOODLANDS,…
Event featuring David T. Ahn, MD from Hoag Medical Group and Jeff Ciaramita, MD from Mercy health system, along with managementGERMANTOWN, Md., Oct.…
WARREN, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage…
SAN DIEGO, Oct. 16, 2024 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based…
RADNOR, Pa., Oct. 16, 2024 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today…
IRVINE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) — Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, announced today that CEO…
In vitro data on SPR719 show low propensity for resistance development in NTM-PD MAC strains when administered as a single…
Poster presentation highlights SMART adenine base editors (ABEs)small enough to be packaged into a single adeno-associated virus (AAV) Data demonstrate…
WARREN, N.J., Oct. 14, 2024 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage…
Data presentations highlight the results for FILSPARI® (sparsentan), the only approved kidney-targeted medicine for IgA nephropathy, when used as a…